ALLIANCEBERNSTEIN L.P. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$423,000
-12.1%
181,411
+7.1%
0.00%
Q4 2017$481,000
-5.5%
169,311
-4.8%
0.00%
Q3 2017$509,000
+15.9%
177,9110.0%0.00%
Q2 2017$439,000
+4.0%
177,911
+52.2%
0.00%
Q1 2017$422,000
-11.9%
116,911
-13.6%
0.00%
Q4 2016$479,000
-26.3%
135,311
-16.0%
0.00%
-100.0%
Q3 2016$650,000
-8.1%
161,0110.0%0.00%0.0%
Q2 2016$707,000
+4.7%
161,011
-9.8%
0.00%0.0%
Q1 2016$675,000
-75.9%
178,5110.0%0.00%
-50.0%
Q4 2015$2,799,000
+48.7%
178,5110.0%0.00%0.0%
Q3 2015$1,882,000
-58.2%
178,511
-0.1%
0.00%
-50.0%
Q2 2015$4,507,000
-6.2%
178,691
+3.6%
0.00%0.0%
Q1 2015$4,807,000
+52.7%
172,4910.0%0.00%
+33.3%
Q4 2014$3,148,000
+36.8%
172,491
-2.8%
0.00%
+50.0%
Q3 2014$2,301,000
-23.9%
177,541
-4.2%
0.00%
-33.3%
Q2 2014$3,023,000
-78.9%
185,233
-77.2%
0.00%
-75.0%
Q1 2014$14,357,000
-34.7%
812,534
-10.6%
0.01%
-40.0%
Q4 2013$22,002,000
-50.0%
908,785
-26.9%
0.02%
-54.5%
Q3 2013$44,037,000
+101.5%
1,242,917
-11.2%
0.04%
+91.3%
Q2 2013$21,856,0001,400,0990.02%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2016
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders